Recent approval of Eli Lilly’s Alzheimer’s drug donanemab is another treatment option that while improving slightly the patient’s state has major benefits and risks. ...
Recent approval of Eli Lilly’s Alzheimer’s drug donanemab is another treatment option that while improving slightly the patient’s state has major benefits and risks. ...